Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Mol Cell. 2023 Jun 15;83(12):1956-1958. doi: 10.1016/j.molcel.2023.05.007.
In this issue of Molecular Cell, Yu et al. identify RBM33 as a previously unrecognized mA (N-6-methyladenosine) RNA binding protein that plays a critical role in ALKBH5-mediated mA demethylation of a subset of mRNA transcripts by forming a complex with ALKBH5.
在本期《分子细胞》中,于等人发现 RBM33 是一种以前未被识别的 mA(N-6-甲基腺苷)RNA 结合蛋白,它通过与 ALKBH5 形成复合物,在 ALKBH5 介导的一组 mRNA 转录物的 mA 去甲基化中发挥关键作用。